| Literature DB >> 26051715 |
Serena Muratcioglu1, Tanmay S Chavan2, Benjamin C Freed3, Hyunbum Jang4, Lyuba Khavrutskii4, R Natasha Freed3, Marzena A Dyba5, Karen Stefanisko3, Sergey G Tarasov6, Attila Gursoy7, Ozlem Keskin1, Nadya I Tarasova3, Vadim Gaponenko8, Ruth Nussinov9.
Abstract
Ras proteins recruit and activate effectors, including Raf, that transmit receptor-initiated signals. Monomeric Ras can bind Raf; however, activation of Raf requires its dimerization. It has been suspected that dimeric Ras may promote dimerization and activation of Raf. Here, we show that the GTP-bound catalytic domain of K-Ras4B, a highly oncogenic splice variant of the K-Ras isoform, forms stable homodimers. We observe two major dimer interfaces. The first, highly populated β-sheet dimer interface is at the Switch I and effector binding regions, overlapping the binding surfaces of Raf, PI3K, RalGDS, and additional effectors. This interface has to be inhibitory to such effectors. The second, helical interface also overlaps the binding sites of some effectors. This interface may promote activation of Raf. Our data reveal how Ras self-association can regulate effector binding and activity, and suggest that disruption of the helical dimer interface by drugs may abate Raf signaling in cancer.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26051715 PMCID: PMC4497850 DOI: 10.1016/j.str.2015.04.019
Source DB: PubMed Journal: Structure ISSN: 0969-2126 Impact factor: 5.006